Fluidic Device for Rapid Antibiotic Susceptibility Testing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for determining antibiotic susceptibility of microorganisms, such as bacteria, are limited by long incubation times, inability to test multiple antibiotic concentrations, and low sensitivity, particularly in two-dimensional culture systems.
Innovation Solution
A fluidic device with a three-dimensional culture matrix and flanking fluid channels creating a concentration gradient of test substances allows for rapid determination of microorganism responses by identifying border zones between different response zones, enabling the testing of a continuous range of concentrations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If traditional 2D culture methods (LB agar plates) are used for antibiotic susceptibility testing, then the culture setup is simple and easy to manufacture, but the incubation time is long (overnight to 24 hours) and only a single antibiotic concentration can be tested per plate
Solution Approach 1:
The patent transitions from traditional 2D agar plate culture to a 3D microfluidic culture system. The microfluidic device creates a three-dimensional concentration gradient of antibiotic through fluid flow in channels, enabling simultaneous testing of multiple concentrations and significantly reducing incubation time while maintaining ease of setup through integrated microfabrication
2Device complexity
If traditional 2D culture methods are used, then the device complexity is low, but the measurement precision and sensitivity are insufficient for accurate MIC determination
Solution Approach 1:
The patent creates a three-dimensional concentration gradient in the microfluidic device, allowing precise spatial mapping of antibiotic concentrations. This 3D gradient enables accurate determination of minimum inhibitory concentrations through border zone analysis, significantly improving measurement precision while the microfluidic platform itself remains relatively simple to manufacture
Solution Approach 2:
The microfluidic device creates locally distinct zones with different antibiotic concentrations within the same culture chamber. The concentration gradient varies continuously from one region to another, allowing precise local measurement of microbial responses at specific antibiotic concentrations, thereby improving MIC determination accuracy
3Adaptability or versatility
If E-test strips or microtiter plate assays are used, then multiple concentrations can be tested, but the incubation time remains long (24 hours) and readouts are limited to distinct digital steps
Solution Approach 1:
The microfluidic device establishes a continuous concentration gradient of antibiotic through controlled fluid flow. This continuous gradient allows the system to simultaneously test multiple concentrations and provide continuous readout data throughout the incubation period, dramatically reducing the 24-hour incubation time required by traditional methods while maintaining the ability to test multiple concentrations
4Loss of time
If droplet-based microfluidic systems are used to reduce AST time, then incubation time is reduced, but only a single antibiotic concentration can be tested
Solution Approach 1:
Instead of using discrete droplets, the patent creates a continuous three-dimensional concentration gradient within a single microfluidic culture chamber. This spatial gradient enables multiple antibiotic concentrations to be tested simultaneously in one device, maintaining reduced incubation time while significantly increasing the versatility of the system
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly reduces testing time, enhances sensitivity, and allows for the efficient determination of minimum inhibitory concentrations, providing a more accurate and rapid assessment of microorganism responses to various test substances.
Implementation Method 1
connecting an input of the second fluid channel to a second fluid flow lacking the test substance or comprising the test substance at a second concentration that is lower than the first concentration to from a concentration gradient of the test substance over at least a portion of the 3D culture matrix
Data Source
AI summary
A fluidic device has a culture chamber configured to house a 3D culture matrix comprising a culture of microorganisms. A concentration gradient of a test substance is established over the 3D culture matrix by providing respective fluid flows at different end portions of the culture chamber and comprising different concentrations of the test substance. The response of the microorganisms to the test substance is determined based on the position of a border zone in the 3D culture matrix.